Scott W. Sharkey

Scott W. Sharkey

Auto-generated profile, based on publicly available information

Scott W. Sharkey

Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2019 in JACC
Verified
Journal Article
Closed access
ALAngie S. Lobo
Angie S. Lobo
SCStephanie M. Cantu
Stephanie M. Cantu
SSScott W. Sharkey
Scott W. Sharkey
EGElizabeth Z. Grey
Elizabeth Z. Grey
KSKatelyn Storey
Katelyn Storey
THTimothy D. Henry
Timothy D. Henry

7 August 2020 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Open access
PDF file
SGSantiago Garcia
Santiago Garcia
LSLarissa Stanberry
Larissa Stanberry
CSChristian Schmidt
Christian Schmidt
SSScott Sharkey
Scott Sharkey
MMMichael Megaly
Michael Megaly
Timothy HenryTimothy Henry
Timothy Henry
Objective: To evaluate the impact of COVID‐19 pandemic migitation measures on of ST‐elevation myocardial infarction (STEMI) care.Background: We previously reported a 38% decline in cardiac catheterization activations during the early phase of the COVID‐19 pandemic mitigation measures. This study extends our early observations using a larger sample of STEMI programs representative of different US regions with the inclusion of more contemporary data.Methods: Data from 18 hospitals or healthcare systems in the US from January 2019 to April 2020 were collecting including number activations for STEMI, the number of activations leading to angiography and primary percutaneous coronary intervention (PPCI), and average door to balloon (D2B) times. Two periods, January 2019–February 2020 and March–April 2020, were defined to represent periods before (BC) and after (AC) initiation of pandemic mitigation measures, respectively. A generalized estimating equations approach was used to estimate the change in response variables at AC from BC.Results: Compared to BC, the AC period was characterized by a marked reduction in the number of activations for STEMI (29%, 95% CI:18–38, p < .001), number of activations leading to angiography (34%, 95% CI: 12–50, p = .005) and number of activations leading to PPCI (20%, 95% CI: 11–27, p < .001). A decline in STEMI activations drove the reductions in angiography and PPCI volumes. Relative to BC, the D2B times in the AC period increased on average by 20%, 95%CI (−0.2 to 44, p = .05).Conclusions: The COVID‐19 Pandemic has adversely affected many aspects of STEMI care, including timely access to the cardiac catheterization laboratory for PPCI.

1 February 2009 in Journal of Cardiology
Verified
Journal Article
Closed access
SSScott W. Sharkey
Scott W. Sharkey
BMBarry J. Maron
Barry J. Maron
PNPenny Nelson
Penny Nelson
MPMary Parpart
Mary Parpart
MMMartin S. Maron
Martin S. Maron
MBMichael R. Bristow
Michael R. Bristow

1 November 2011 in Circulation
Verified
Journal Article
Closed access
PDF file
SSScott W. Sharkey
Scott W. Sharkey
JLJohn R. Lesser
John R. Lesser
BMBarry J. Maron
Barry J. Maron
Whenever a new and previously unrecognized medical condition enters our consciousness, considerable confusion and uncertainly can ensue. If a patient is afflicted by such a disease state, the natural reaction is, “I have never heard of what I have,” triggering considerable personal and family anxiety. Such is the case with the condition we now call takotsubo cardiomyopathy, which has received considerable attention from the media and has been assigned a myriad of names in the literature. Initial recognition of takotsubo cardiomyopathy occurred in Japan in 1990, with the first report emerging from the United States in 1998. Thereafter, scientific interest in this condition has increased steadily and dramatically. For example, in 2000, only 2 publications were recorded, compared with nearly 300 in 2010 (Figure 1). Now, takotsubo is widely recognized, with reports from 6 continents and diverse countries, including France, Belgium, Mexico, Australia, Spain, South Korea, China, Brazil, Germany, Israel, South Africa, Turkey, and Iceland. Figure 1. Increasing number of takotsubo cardiomyopathy publications by year, 2000 to 2010. ### The Acute Illness Takotsubo cardiomyopathy starts abruptly and unpredictably, with symptoms of chest pain and, often, shortness of breath, usually triggered by an emotionally or physically stressful event, and with a predilection for women older than 50 years of age …

1 September 2015 in The American Journal of Cardiology
Verified
Journal Article
Closed access
SSScott W. Sharkey
Scott W. Sharkey
VPVictoria R. Pink
Victoria R. Pink
JLJohn R. Lesser
John R. Lesser
RGRoss F. Garberich
Ross F. Garberich
MMMartin S. Maron
Martin S. Maron
BMBarry J. Maron
Barry J. Maron

12 April 2023 in JACC: Cardiovascular Imaging
Verified
Journal Article
Closed access
MGMario Gössl
Mario Gössl
LSLarissa Stanberry
Larissa Stanberry
GBGretchen Benson
Gretchen Benson
ESElizabeth Steele
Elizabeth Steele
RGRoss Garberich
Ross Garberich
MEMaurice Enriquez-Sarano
Maurice Enriquez-Sarano